Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nuvation Bio (NUVB) Net Income (2023 - 2025)

Historic Net Income for Nuvation Bio (NUVB) over the last 3 years, with Q3 2025 value amounting to -$55.8 million.

  • Nuvation Bio's Net Income fell 3538.46% to -$55.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$217.5 million, marking a year-over-year increase of 5914.19%. This contributed to the annual value of -$567.9 million for FY2024, which is 64924.01% down from last year.
  • As of Q3 2025, Nuvation Bio's Net Income stood at -$55.8 million, which was down 3538.46% from -$59.0 million recorded in Q2 2025.
  • Over the past 5 years, Nuvation Bio's Net Income peaked at -$13.8 million during Q4 2023, and registered a low of -$462.5 million during Q2 2024.
  • Its 3-year average for Net Income is -$73.8 million, with a median of -$41.2 million in 2024.
  • Its Net Income has fluctuated over the past 5 years, first crashed by 214075.58% in 2024, then soared by 8724.15% in 2025.
  • Over the past 3 years, Nuvation Bio's Net Income (Quarter) stood at -$13.8 million in 2023, then tumbled by 258.63% to -$49.4 million in 2024, then decreased by 12.84% to -$55.8 million in 2025.
  • Its Net Income stands at -$55.8 million for Q3 2025, versus -$59.0 million for Q2 2025 and -$53.2 million for Q1 2025.